Abstract
Background:
There is no external quality assessment (EQA) program for hemoglobin analysis that uses lyophilized hemoglobin control materials with HbA2/E in levels as high as those found in people with the β-thalassemia trait, HbE trait, β-thalassemia/HbE disease or homozygous HbE; these are all found frequently in the southeast Asian population. The aim of this study was to evaluate the efficiency of the control materials used in the established proficiency testing (PT) program at the Associated Medical Sciences-Clinical Service Center (AMC-CSC), Chiang Mai University, Chiang Mai, Thailand.
Methods:
The PT program for Hb analysis and the thalassemia interpretation was established in compliance with ISO/IEC17043:2010. Three cycles per year were performed in 2015 and 2016. In each cycle, three different types of control material were provided to the participants. Each participant analyzed the control materials in the same manner as in their routine practices. Hb analysis results and their thalassemia interpretation codes were entered into the report form and sent back to AMC-CSC.
Results:
The number of participants increased from 63 in 2015 to 76 in 2016. In addition, the number of participants who took part in all three cycles increased from 95.2% (60/63) in 2015 to 100% (76/76) in 2016. All participants reported the correct Hb measurement and type; however, misinterpretations in thalassemia diagnosis were noted.
Conclusions:
The lyophilized hemoglobin control materials prepared at AMC-CSC were used successfully in our PT program. However, the study results indicate the need for further improvement in thalassemia interpretation skills for laboratory staff.
Acknowledgments
The authors thank the technicians in the Associated Medical Sciences Clinical Service Center, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand for their help and assistance.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Fucharoen S, Winichagoon P, Thonglairuam V. Beta-thalassemia associated with alpha-thalassemia in Thailand. Hemoglobin 1988;12:581–92.10.3109/03630268808991648Search in Google Scholar PubMed
2. Tanphaichitr VS, Mahasandana C, Suvatte V, Yodthong S, Pung-amritt P, Seeloem J. Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok. Southeast Asian J Trop Med Public Health 1995;26:271–4.Search in Google Scholar
3. Fucharoen S, Winichagoon P. Thalassemia in southeast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health 1992;23:647–55.Search in Google Scholar
4. Sirichotiyakul S, Tantipalakorn C, Sanguansermsri T, Wanapirak C, Tongsong T. Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy. Int J Gynaecol Obstet 2004;86:347–50.10.1016/j.ijgo.2004.04.037Search in Google Scholar PubMed
5. Nathalang O, Nillakupt K, Arnutti P, Boonsiri T, Panichkul S, Areekul W. Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study. J Med Assoc Thai 2005;88:35–42.Search in Google Scholar
6. Tatsumi N, Tsuda I, Funahara Y, Bunyaratvej A, Fucharoen S. Automatic measurement of hemoglobin F in blood obtained from patients with hemoglobin E/E and beta-thalassemia/hemoglobin/E. Southeast Asian J Trop Med Public Health 1992;23:91–4.Search in Google Scholar
7. Tatsumi N, Tsuda I, Funahara Y, Bunyaratvej A, Pootrakul P, Fucharoen S. Analysis of hematological data of thalassemia cases in Thailand. Nippon Ketsueki Gakkai Zasshi 1989;52: 792–5.Search in Google Scholar
8. Fucharoen S, Winichagoon P. Haemoglobinopathies in southeast Asia. Indian J Med Res 2011;134:498–506.Search in Google Scholar
9. Van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld CL, et al. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol 2009;31:484–95.10.1111/j.1751-553X.2009.01158.xSearch in Google Scholar PubMed
10. Pornprasert S, Phusua A, Suanta S, Saetung R, Sanguansermsri T. Detection of alpha-thalassemia-1 southeast Asian type using real-time gap-PCR with SYBR Green1 and high resolution melting analysis. Eur J Haematol 2008;80:510–4.10.1111/j.1600-0609.2008.01055.xSearch in Google Scholar PubMed
11. Pornprasert S, Wiengkum T, Srithep S, Chainoi I, Singboottra P, Wongwiwatthananukit S. Detection of alpha-thalassemia-1 southeast Asian and Thai type deletions and beta-thalassemia 3.5-kb deletion by Single-tube Multiplex Real-time PCR with SYBR Green1 and high-resolution melting analysis. Korean J Lab Med 2011;31:138–42.10.3343/kjlm.2011.31.3.138Search in Google Scholar
12. Pornprasert S, Kongthai K, Waneesorn J, Jaiping K, Treesuwan K. Development of control material for hemoglobin analysis. Clin Chem Lab Med 2011;50:351–6.10.1515/cclm.2011.777Search in Google Scholar PubMed
13. Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ 2004;82:364–72.Search in Google Scholar
14. Karnpean R, Fucharoen G, Pansuwan A, Changtrakul D, Fucharoen S. A proficiency testing program of hemoglobin analysis in prevention and control of severe hemoglobinopathies in Thailand. Clin Chem Lab Med 2013;51:1265–71.10.1515/cclm-2012-0588Search in Google Scholar PubMed
15. Sanchaisuriya K, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya P, Changtrakul Y, et al. A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy: an alternative approach to electronic blood cell counting. Am J Clin Pathol 2005;123:113–8.10.1309/FUF9EVGQ24V1PKTPSearch in Google Scholar PubMed
16. Olivieri NF. The beta-thalassemias. N Engl J Med 1999;341: 99–109.10.1056/NEJM199907083410207Search in Google Scholar PubMed
17. Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005;1054:18–24.10.1196/annals.1345.003Search in Google Scholar PubMed
18. Wong HB. Prevention of thalassaemias in south-east Asia. Ann Acad Med Singapore 1985;14:654–65.Search in Google Scholar
19. Yamsri S, Singha K, Prajantasen T, Taweenan W, Fucharoen G, Sanchaisuriya K, et al. A large cohort of beta(+)-thalassemia in Thailand: molecular, hematological and diagnostic considerations. Blood Cells Mol Dis 2015;54:164–9.10.1016/j.bcmd.2014.11.008Search in Google Scholar PubMed
20. Charoenkwan P, Wanapirak C, Thanarattanakorn P, Sekararithi R, Sae-Tung R, Sittipreechacharn S, et al. Hemoglobin E levels in double heterozygotes of hemoglobin E and SEA-type alpha-thalassemia. Southeast Asian J Trop Med Public Health 2005;36:467–70.Search in Google Scholar
21. Merono F, Agouti I, Bonello-Palot N, Paolasso C, Levy N, Badens C. Analytical evaluation of the Tosoh HLC-723 G8 automated HPLC analyzer for hemoglobin analysis in beta-thalassemia mode. Clin Biochem 2011;44:441–3.10.1016/j.clinbiochem.2010.12.007Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston
